Wencai Ma

View Scopus Profile

h-index

Research activity per year

54 Article
3 Comment/debate
2 Conference contribution
1 Editorial
More
- 1 Letter

3 results

Filter

2022
Correction: Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia (Signal Transduction and Targeted Therapy, (2022), 7, 1, (51), 10.1038/s41392-021-00870-3)
Zhang, Q., Riley-Gillis, B., Han, L., Jia, Y., Lodi, A., Zhang, H., Ganesan, S., Pan, R., Konoplev, S. N., Sweeney, S. R., Ryan, J. A., Jitkova, Y., Dunner, K., Grosskurth, S. E., Vijay, P., Ghosh, S., Lu, C., Ma, W., Kurtz, S. & Ruvolo, V. R. & 21 others, Ma, H., Weng, C. C., Ramage, C. L., Baran, N., Shi, C., Cai, T., Davis, R. E., Battula, V. L., Mi, Y., Wang, J., DiNardo, C. D., Andreeff, M., Tyner, J. W., Schimmer, A., Letai, A., Padua, R. A., Bueso-Ramos, C. E., Tiziani, S., Leverson, J., Popovic, R. & Konopleva, M., Dec 2022, In: Signal Transduction and Targeted Therapy. 7, 1, 110.
Research output: Contribution to journal › Comment/debate › peer-review

Open Access
2 Scopus citations
2015

Errata: Antileukemia activity of the novel peptidic CXCR4 antagonist LY2510924 as monotherapy and in combination with chemotherapy (Blood (2015) 126, 2 (222-232))
Cho, B. S., Zeng, Z., Mu, H., Wang, Z., Konoplev, S., McQueen, T., Protopopova, M., Cortes, J., Marszalek, J. R., Peng, S. B., Ma, W., Davis, R. E., Thornton, D. E., Andreeff, M. & Konopleva, M., Aug 20 2015, In: Blood. 126, 8, p. 1049 1 p.
Research output: Contribution to journal › Comment/debate › peer-review

Open Access
2009

Erratum: Edge-based scoring and searching method for identifying condition-responsive protein-protein interaction sub-network (Bioinformatics (2009) vol. 23 (16) (2121-2128))
Guo, Z., Li, Y., Gong, X., Yao, C., Ma, W., Wang, D., Li, Y., Zhu, J., Zhang, M., Yang, D. & Wang, J., 2009, In: Bioinformatics. 25, 12, p. 1574 1 p.
Research output: Contribution to journal › Comment/debate › peer-review

Open Access

2 Scopus citations

Wencai Ma

Research output

Search results

Correction: Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia (Signal Transduction and Targeted Therapy, (2022), 7, 1, (51), 10.1038/s41392-021-00870-3)

Errata: Antileukemia activity of the novel peptidic CXCR4 antagonist LY2510924 as monotherapy and in combination with chemotherapy (Blood (2015) 126, 2 (222-232))

Erratum: Edge-based scoring and searching method for identifying condition-responsive protein-protein interaction sub-network (Bioinformatics (2009) vol. 23 (16) (2121-2128))